VERSUS TECHNOLOGY INC
10QSB, 1997-09-16
COMMUNICATIONS EQUIPMENT, NEC
Previous: NORTH COAST ENERGY INC / DE/, SC 13D, 1997-09-16
Next: RAINBOW MEDICAL INC /, 8-K, 1997-09-16



SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

FORM 10-QSB

(X)      QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
         SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD
         ENDED July 31, 1997

( )      TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE  
         SECURITIES EXCHANGE ACT OF 1934

Commission File No. 0-17500


VERSUS TECHNOLOGY, INC.
(Exact name of Small Business Issuer as specified in its charter)


            Delaware                                   22-2283745        
(State or other jurisdiction of               (I. R. S. Employer   
     Incorporation or Organization)               Identification Number)


2600 Miller Creek Road
Traverse City, Michigan 49684
(Address of principal executive offices)

616-946-5868
Registrant's telephone number

Check whether the issuer (1) has filed all reports required to be filed 
by Section 13 or 15(d) of the Exchange Act during the past twelve months 
(or for such shorter period that the registrant was required to file 
such reports), and (2) has been subject to such filing requirements for 
the past 90 days:

Yes    X       No     

Number of shares of Common Stock, par value $.01 per share,
outstanding as of September 12, 1997: 38,157,149.

Transitional small business disclosure format:  

Yes_____    No __X__


VERSUS TECHNOLOGY, INC.

Index



PART I - FINANCIAL INFORMATION

            Item 1 - Financial Statements:

                         Consolidated Balance Sheets as of 
                             July 31, 1997 (Unaudited) and 
                             October 31, 1996                        

                         Consolidated Statements of Operations 
                             for the three and nine months ended 
                             July 31, 1997 and 1996 (Unaudited)      

                         Consolidated Statement of Cash Flows for 
                             the nine months ended
                             July 31, 1997 and 1996 (Unaudited)

                         Notes to Consolidated Financial Statements  

            Item 2 - Management's Discussion and Analysis of
                         Financial Condition and Results of
                         Operations                                  


PART II - OTHER INFORMATION                                          

            Item 1 - Legal Proceedings                               

            Item 6 - Exhibits and Reports on Form 8-K                

            Signatures                                               

VERSUS TECHNOLOGY, INC.
 Consolidated Balance Sheets
<TABLE>
<CAPTION>
ASSETS
                                             July 31,        October 31,
                                               1997             1996
                                           (Unaudited)
<S>                                        <C>             <C>
Current Assets
  Cash and cash equivalents                $ 2,884,000     $  4,931,000
  Accounts receivable, 
    net of allowance for doubtful
    accounts of $68,000 at July 31,
    1997 and $53,000 October 31, 1996          265,000          154,000
  Notes receivable, net                         47,000           32,000
  Inventories - purchased parts
     and assemblies                            154,000          145,000
  Prepaid expenses and other
     current assets                             82,000           80,000

          Total Current Assets               3,432,000        5,342,000

Notes Receivable, net                             -              19,000

Property and Equipment, net
    of accumulated depreciation                          
    of $178,000 and $155,000                   298,000          270,000

Software Development Costs,
    net of accumulated amortization
    of $69,000 and $12,000                     531,000          588,000

Goodwill, net of accumulated
    amortization of $143,000 and 
    $26,000                                  2,196,000        2,313,000

Patents and Other Intangible Assets,      
    net of accumulated amortization
    of $291,000 and $170,000                 1,675,000          255,000


                                           $ 8,132,000     $  8,787,000

</TABLE>

<TABLE>
<CAPTION>
LIABILITIES AND SHAREHOLDERS'
EQUITY

                                             July 31,        October 31,
                                               1997             1996
                                          (Unaudited)
<S>                                       <C>              <C>

Current Liabilities
  Accounts payable                         $   357,000     $    748,000
  Accounts payable, PTFM                       250,000             -
  Accrued expenses                             274,000          135,000
  Deferred revenue-customer 
    advance payments                           369,000           16,000
  Note payable -- current portion              344,000          367,000

          Total Current Liabilities          1,594,000        1,266,000

          Total Liabilities                  1,594,000        1,266,000



Shareholders' Equity
  Common stock, $.01 par value;
  50,000,000 shares authorized;
  38,157,149 and 36,543,573 shares
  issued and outstanding                       381,000          366,000
  Additional paid-in capital                32,888,000       31,910,000
  Accumulated deficit                      (26,575,000)     (24,532,000)
  Unearned compensation                       (156,000)        (223,000)

          Total Shareholders' Equity         6,538,000        7,521,000

                                           $ 8,132,000     $  8,787,000	
</TABLE>
See accompanying notes to consolidated financial statements.

VERSUS TECHNOLOGY, INC.
Consolidated Statement of Operations
(Unaudited)
<TABLE>
<CAPTION>
                          Three Months Ended        Nine Months Ended
                                July 31,                July 31,
                         1997            1996     1997             1996
<S>                      <C>         <C>          <C>          <C>
Net Sales                $306,000    $ 67,000     $992,000     $160,000

Cost of sales             146,000      60,000      485,000      124,000

Gross profit              160,000       7,000      507,000       36,000

Operating Expenses
  Research & development   43,000     123,000      188,000      415,000
  Sales, general and 
    administrative        926,000     267,000    2,317,000      785,000
  Litigation defense 
    costs, settlements
    and judgments          21,000      12,000      144,000       53,000
                          990,000     402,000    2,649,000    1,253,000

Loss From Operations     (830,000)   (395,000)  (2,142,000)  (1,217,000)

Other Income (Expense)
  Interest income          34,000       5,000      119,000       41,000
  Interest expense         (6,000)    (16,000)     (20,000)     (32,000)
  Other, net                5,000        -          (1,000)  (    -    )
                           33,000     (11,000)      98,000        9,000

Net Loss                $(797,000)  $(406,000) $(2,044,000) $(1,208,000)

Net Loss Per Share    $    (.02)  $    (.02)  $     (.05)   $    (.06)
     
</TABLE>
     See accompanying notes to consolidated financial statements.

VERSUS TECHNOLOGY, INC.
Consolidated Statements of Cash Flow
(Unaudited)
<TABLE>
<CAPTION>
                                                 Nine Months Ended
                                                     July 31,        
                                                1997          1996
<S>                                        <C>             <C>
Cash flows from operating activities:
Net Loss                                   $(2,044,000)    $(1,208,000)

Adjustments to reconcile net loss to net
    cash used in operating activities:
  Depreciation and amortization                344,000          49,000
  Change in unearned compensation               35,000            -
  Directors' compensation                       26,000            -
  Loss on sale of equipment                      2,000            -

Changes in operating assets and
  liabilities:
  Accounts receivable                         (111,000)         56,000
  Inventories                                   (9,000)        (33,000)
  Prepaid expenses and other current
  assets                                       (27,000)        (70,000)
  Accounts payable and other liabilities      (391,000)       (222,000)
  Accrued expenses                             139,000         (18,000)
  Deferred revenues- customer advance
  payments                                     353,000          (9,000)
  Total adjustments                            361,000        (247,000)
    Net cash used in operating activities   (1,683,000)     (1,455,000)

Cash flows from investing activities:
  Changes in notes receivable                    4,000            -
  Payment for acquisition of license to
    intellectual property and associated
    costs                                     (265,000)           -
  Additions to property and equipment          (95,000)        (72,000)
  Proceeds from sale of equipment               15,000            -
  Additions to deferred charges and
    other assets                                  -            (59,000)
  Net cash provided by investing
    activities                                (341,000)       (131,000)

Cash flows from financing activities:
  Payments on notes payable                    (23,000)        (56,000)
  Purchase of treasury stock                      -            (85,000)
  Issuance of common stock                        -            159,000 
  Net cash provided by (used in)
    financing activities                       (23,000)         18,000 


Net decrease in cash and cash
  equivalents                               (2,047,000)     (1,568,000)

Cash and cash equivalents,
  beginning of period                        4,931,000       1,998,000
Cash and cash equivalents, 
  end of period                             $2,884,000        $430,000

Supplemental disclosures of cash flow
  information 
  
Cash paid during the period for interest        $7,000         $32,000
</TABLE>

During the first nine months of fiscal 1997 the Company repurchased non-
vested Employee Incentive Stock from terminated employees at par value, 
pursuant to the 1996 Incentive Restricted Stock Bonus Plan, canceling 
the unearned compensation of $39,000 related to those shares.

Effective January 31, 1997, the Company acquired a license to 
intellectual property from Precision Tracking, FM, Inc. for 
consideration of 1,600,000 shares of common stock, valued for accounting 
purposes at $1,000,000, and $500,000 of which $250,000 was paid during 
the quarter ended April 30, 1997 and $250,000 is recorded as Accounts 
Payable, PTFM at July 31,1997.  Expenses related to the acquisition 
totaling $15,000 were capitalized and $25,000 of prepaid royalties were 
re-classified from prepaid expenses to intellectual properties to be 
amortized over 10 years.

     See accompanying notes to consolidated financial statements.

VERSUS TECHNOLOGY, INC. AND SUBSIDIARY
Notes to Consolidated Financial Statements
July 31, 1997
(Unaudited)
================================================================
Note 1    Basis of Presentation

The accompanying unaudited consolidated financial statements, which are 
for interim periods, do not include all disclosures provided in the 
annual consolidated financial statements. They should be read in 
conjunction with the consolidated financial 
statements and the footnotes thereto contained in the Annual Report on 
Form 10-KSB for the year ended October 31, 1996 of Versus Technology, 
Inc. and subsidiary (the Company), as filed with the Securities and 
Exchange Commission.  The October 31, 1996 balance sheet contained 
herein was derived from audited consolidated financial statements, but 
does not include all disclosures required by generally accepted 
accounting principles as filed in the Company's Annual Report on Form 
10-KSB referenced above.

In the opinion of the Company, the accompanying unaudited consolidated 
financial statements include all adjustments, consisting only of normal 
recurring adjustments, necessary to present fairly the financial 
position as of July 31, 1997, the results of operations for the three 
months and nine months ended July 31, 1997 and 1996 and cash flows for 
the nine months ended July 31, 1997 and 1996. The results of operations 
for the three months and nine months ended July 31, 1997 are not 
necessarily indicative of the results to be expected for the full year.

Note 2    New Accounting Standards Not Yet Adopted

In February 1997, the Financial Accounting Standards Board (FASB) issued 
Statement of Financial Accounting Standards (SFAS) No. 128, "Earnings 
Per Share".  SFAS No. 128 simplifies the standards for computing 
earnings per share (EPS) and makes them comparable to international EPS 
standards.  The statement requires the presentation of both basic and 
diluted EPS on the face of the statement of operations with a 
supplementary reconciliation of the numerators and denominators used in 
the calculations.  SFAS No. 128 is effective for financial statements 
issued for periods ending after December 15, 1997, including interim 
periods; earlier application is not permitted.  Had SFAS No. 128 been 
required to be implemented for the quarter ended July 31, 1997 there 
would have been no effect on EPS.

In June 1997, the FASB issued SFAS No. 131, "Disclosures about Segments 
of an Enterprise and Related Information", which supersedes SFAS No. 14, 
"Financial Reporting for Segments of a Business Enterprise".  SFAS No. 
131 establishes standards for the way that public companies report 
information about operating segments in annual financial statements and 
requires reporting of selected information about operating segments in 
interim financial statements issued to the public.  It also establishes 
standards for disclosures regarding products and services, geographic 
areas and major customers.  SFAS No. 131 defines operating segments as 
components of a company about which separate financial information is 
available that is evaluated regularly by the chief operating decision 
maker in deciding how to allocate resources and in assessing 
performance.  SFAS No. 131 is effective for financial statements for 
periods beginning after December 15, 1997 and requires comparative 
information for prior years to be restated.  Because of the recent 
issuance of this standard, management has been unable to fully evaluate 
the impact, if any, it may have on future financial statement 
disclosures.  Results of operations and financial position, however, 
will be unaffected by implementation of this standard.

Note 3    Acquisition

As described more fully in Note 3 to the Consolidated Financial 
Statements included in the Form 10-KSB for the year ended October 31, 
1996, on August 26, 1996, the Company acquired Olmsted Engineering, Co. 
in a transaction accounted for using the purchase method.  While the 
acquisition occurred on August 26, 1996, the following pro forma 
information reflects operations for the three and nine months ended July 
31, 1996 as if the acquisition took place on November 1, 1995.

                            Three Months                  Nine Months

Net Sales                     $193,000                     $538,000
Net Loss                      (454,000)                  (1,354,000)
Net Loss per Common Share       (.02)                        (.06)

Note 4    Notes Payable

Term Note

On August 1, 1995, the Company signed a note payable to one of its 
former law firms for $449,000 as partial payment of fees billed. The 
note bears interest at a specified bank's prime rate, 8.50% at July 31, 
1997, and requires monthly installments of $10,000 each, including 
interest, commencing on December 1, 1995, with a balloon payment for the 
remaining balance due on January 1, 1997. The note, amounting to 
$344,000 and $367,000 at July 31, 1997 and October 31, 1996, 
respectively, is secured by a portion of the Company's patents and 
intellectual property.  Approximately $150,000 of additional fees to the 
same law firm are included in accounts payable at July 31, 1997 and 
October 31, 1996.

In May 1997, the Company filed a malpractice law suit against the former 
law firm, seeking indemnity against any loss the Company might incur in 
connection with certain class action law suits, and also seeking 
equitable relief against the claim by the law firm that the Company is 
indebted to the law firm for prior legal services. Management intends to 
dispute the amount and terms of payment of the remaining unpaid 
balances.  Any adjustment of the unpaid balance will be recognized in 
the period in which the Company is released from its obligation.

Note 5    Contingencies


Litigation

In addition to the litigation referenced under note 4, the following is 
a summary of other material litigation in which the Company is currently 
engaged.

A suit was filed in November 1996, and a nearly identical suit was filed 
in January 1997, against the Company alleging that the Company allowed 
certain warrants to expire, which the plaintiffs held, and alleging that 
the plaintiffs were damaged by the warrants' expiration.  The plaintiffs 
also allege that the Company breached the warrant agreement pursuant to 
which the warrants were issued to the plaintiffs and claim that the sale 
by the Company of restricted stock in late 1993 required a downward 
adjustment of the exercise price of the warrants under the warrant 
agreement.  Each sole named plaintiff alleges this action should be 
tried as a class action and alleges he is an appropriate representative 
of the class.  The plaintiffs further allege their claims are 
substantially identical to the claims made by the plaintiff in prior 
litigation of a similar nature which resulted in a judgment upheld on 
appeal during 1996 for $195,000, which involved only 300,000 of the 
2,233,800 Class A warrants at issue.  Apparently, the plaintiffs believe 
the Company has a liability for each of the remaining warrants identical 
to the per warrant liability the Company was found to have for the 
300,000 warrants in the 1996 judgment.  Any loss potential is not 
determinable at this time but if plaintiffs' theory were held to be 
correct, the loss potential could be approximately $1.2 million.  The 
Company disputes the material allegations of the complaints and intends 
to vigorously defend itself against these matters.

In January 1997, a suit was filed by a former employee of the Company 
alleging wrongful discharge. The Company disputes the central 
allegations of the Complaint.  The Company believes that should any 
judgment be rendered against the Company in this matter, it will be less 
than $200,000.  

Note 6   Related Party Transactions

The President and Chief Executive Officer of the Company was also the 
Chief Executive Officer, a member of the Board of Directors and a 
stockholder of Olmsted which was acquired by the Company effective August 
26, 1996.

Olmsted provided a number of resources to the Company for the period 
ended July 31, 1996 including research and development, pass-through 
billings, use of office space and development of a business plan.  
Related party billings for the three and nine months ended July 31, 1996 
totaled $160,000 and $597,000 respectively.

The Company believes that services provided by Olmsted were negotiated at 
arm's length at the fair value of goods and services received.  

The Company and Olmsted moved their principal operating facilities in 
December 1996 to a building that is beneficially owned by the Company's 
President.  The Company and Olmsted have entered into separate five-year 
lease agreements calling for aggregate annual rents of $111,000, 
increasing 4% annually on July 1, 1997 and each July 1 thereafter for the 
term of the lease.  The Company and Olmsted have made combined non-
refundable contributions to leasehold improvements amounting to $104,000, 
in accordance with terms of the lease agreements.  Rent expense for the 
three and nine months ended July 31, 1997 amounted to $28,000 and 
$74,000, respectively.


Item 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
             CONDITION AND RESULTS OF OPERATIONS

General

Versus Technology, Inc. (Versus) and its wholly-owned subsidiary, 
Olmsted Engineering Co. (Olmsted), collectively referred to as "the 
Company" operate in two business segments: security; and systems design 
and engineering.  All Company operations are located in one facility in 
Traverse City, Michigan.

Versus develops and markets products using infrared technology for the 
health care industry and other markets located throughout North America.  
These products permit the instantaneous identification and tracking of 
the location of people and equipment and can be used to control access 
and permit instantaneous two-way communication via two-way speakers and 
telephone lines.  Versus also develops, markets and integrates cellular 
products for the security industry.

Versus acquired Olmsted in August 1996.  Olmsted writes and maintains 
complex software programs for the computer-aided design and computer-
aided manufacturing (CAD/CAM) industry.  It sells its own software under 
the ACU.CARV name, resells third-party software and hardware and 
provides systems support services throughout North America.  It receives 
monthly maintenance and enhancement fees from customers in order to 
receive technical support and semi-annual releases.  Olmsted also 
provides software programming services to support the Versus line of 
products.

The Company is continuing its development and marketing of infrared 
products and expects this product line to continue to be the Company's 
primary focus through the remainder of fiscal 1997 and during fiscal 
1998.

The results of the nine months ended July 31, 1997 include non-
repetitive cash expenditures and operating expenses.  Gross margins and 
selling, general and administrative expenses have improved in relation 
to sales levels over the nine months ended July 31, 1996.  The sales for 
the quarter ended July 31, 1997 do not reflect a trend for increasing 
sales, which are expected to occur in ensuing quarters.

Expected sales from Marquette Medical Systems based on the Exclusive 
Marketing Agreement entered into in June 1996, with the Company, have 
not fully materialized.  As a result during the quarter ended July 31, 
1997, negotiations were initiated with Marquette to alter their 
exclusive status for the remainder of the agreement.  It is not possible 
to predict the outcome of the current discussions.

The following discussion and analysis focuses on the significant factors 
which affected the Company's consolidated financial statements during 
the three months and nine months ended July 31, 1997, with comparisons 
to similar periods in 1996 where appropriate.  It also discusses the 
Company's liquidity and capital resources.  The discussion should be 
read in conjunction with the consolidated financial statements and 
related notes included elsewhere in this Form 10-QSB and the 
consolidated financial statements and footnotes thereto contained in the 
Annual Report on Form 10-KSB for the year ended October 31, 1996.

The following table sets forth selected financial data for the Company:
<TABLE>
<CAPTION>
(in thousands except per share data)
Statement of Operations Data:

                                Three Months Ended     Nine Months Ended
                                 July 31,                   July 31,
                                1997          1996     1997         1996
<S>                             <C>         <C>        <C>      <C>
Net Sales                       $306        $ 67       $ 992    $  160
Net Loss                        (797)       (406)     (2,044)   (1,208)
Net Loss Per
  Common Share                  (.02)       (.02)       (.05)     (.06)

Weighted average
  Number of common
  Shares outstanding (000's)    38,132      18,734     37,595   18,710
</TABLE>
<TABLE>
Balance Sheet Data:              July 31,1997          October 31,1996
<S>                              <C>                   <C>
Working capital                     $1,838                   $4,076
Total assets                         8,132                    8,787
Total liabilities                    1,594                    1,266
Shareholders' equity                 6,538                    7,521
</TABLE>

Results of Operations

Three Months Ended July 31, 1997 and July 31, 1996

Net sales for the third quarter of fiscal 1997 of $306,000 were $239,000 
above sales of $67,000 for the corresponding quarter in fiscal 1996. 
This increase is primarily due to the addition of Olmsted sales and 
growth in sales of the infrared tracking systems with sales generated 
from the PTFM license arrangements.  Of the total sales in the third 
quarter of fiscal 1997, approximately 35% were attributable to infrared 
tracking system sales (almost entirely through the PTFM license 
arrangements), 55% to Olmsted sales, and 10% to cellular sales.

Cost of sales as a percentage of sales in the third quarter of fiscal 
1997 decreased to 48% from 90% for the same quarter in fiscal 1996. This 
change was largely attributable to the increase in infrared sales and 
the inclusion of Olmsted sales in third quarter fiscal 1997, both of 
which have higher gross profit margins.

The Company's selling, general and administrative expenses for the third 
quarter of fiscal 1997 increased $659,000, or 247%, over the third 
quarter of fiscal 1996. This increase was primarily due to the 
additional selling and administrative support costs associated with the 
Company's expanded efforts to develop and market its infrared product 
line and the Company's acquisition of Olmsted in August 1996 which 
resulted in the inclusion of the expenses for Olmsted's operations in 
the consolidated financial statements in 1997. Research and development 
expenses for the third quarter of fiscal 1997 were $43,000 compared to 
$123,000 for the third quarter of fiscal 1996. The Company's acquisition 
of Olmsted, the Company's primary source of research and development for 
the IR tracking system in the third quarter of fiscal 1996, resulted in 
reduced research and development costs in the third quarter of fiscal 
1997.

In the third quarter of fiscal 1997, other income, net increased $44,000 
over the 1996 level due primarily to the increase in interest earned on 
the proceeds from the August 1996 private placement.

Nine Months Ended July 31, 1997 and July 31, 1996

Net sales for the nine months ended July 31, 1997 were $992,000 or 6 
times the 1996 level of $106,000.  Infrared tracking sales, which 
totaled $341,000 are up significantly from the 1996 levels.  Sales for 
1997 reflect $341,000 of infrared sales, $559,000 in Olmsted sales and 
$92,000 in cellular products and services.  The sales mix for the first 
nine months of 1997 was 34% infrared, 9% cellular and 57% Olmsted 
services and products.  The Company continued development of its 
marketing and distribution channels.  The January agreement with 
Precision Tracking added significantly to its infrared tracking 
distribution network.  

Cost of sales as a percentage of sales decreased 29% from the 1996 level 
of 78% to 49% in the first nine months of 1997.  This decrease was 
attributable to the inclusion of sales generated from the PTFM license 
arrangements and Olmsted sales in the 1997 results. Sales related to the 
PTFM licensing arrangements and Olmsted sales are relatively high margin 
sales.  Additionally, the Precision Tracking agreements resulted in 
Versus not expending royalty payments (previously included in inventory 
and cost of sales) to PTFM as was the case in 1996.

The Company's selling, general and administrative expenses increased 
from $785,000 in the first nine months of 1996 to $2,317,000 for the 
similar period in 1997.  The increase was primarily due to the 
additional infrared product line selling and administrative support 
costs, the inclusion of Olmsted Engineering expenses in 1997 and costs 
associated with the Precision Tracking Engineering Agreement.  Research 
and development costs decreased $227,000 (55%) from the 1996 level.  As 
mentioned earlier, the Company's acquisition of Olmsted Engineering 
reduced research and development costs for the first nine months of 
1997.

Other income, net increased $89,000 or 11 times the level of the first 
nine months of 1996.  Interest earned on funds from the August 1996 
private placement was the primary cause of the increase.

Liquidity and Capital Resources

During the nine months ended July 31, 1997, the Company relied on cash 
balances from the private placement offering in August 1996, which 
generated net proceeds of $5.2 million. The Company believes that 
current working capital and cash flow from the Marquette relationship 
and other distribution channels should be sufficient to meet projected 
cash needs for the next 12 months.

As discussed in prior filings, as of January 31, 1997, the Company and 
PTFM signed an Agreement (License Agreement) for the Company to become 
the exclusive licensee of PTFM`s patents and other intellectual property 
rights related to infrared tracking technology for ten years, and non-
exclusive thereafter. PTFM has previously been a supplier of infrared 
components to the Company.

Concurrent with executing the License Agreement, a one-year Engineering 
and License Agreement (Engineering Agreement) was entered into by the 
parties to assist the Company in the technology transfer and to support 
the Company in use and development of the technology. 

In consideration of the License Agreement, based on negotiations between 
the parties, the Company agreed to pay $500,000 in cash and 1.6 million 
restricted shares of the Company's common stock. During the quarter 
ended April 30, 1997, $250,000 of the $500,000 obligation was paid.  The 
remaining $250,000 is required to be paid on the completed transfer 
date, defined in the contract as the date all technology has been 
transferred.  Under the Engineering Agreement, the Company is required 
to reimburse PTFM for expenses incurred in providing the services 
covered by the agreement.  Such expense reimbursement payments are 
estimated at $40,000 per month during the one-year term, with additional 
reimbursement of authorized expenses as applicable. 

     Significant liquidity factors are as follows:
<TABLE>
<CAPTION>
                                       July 31,              October 31,
                                         1997                  1996
<S>                                    <C>                   <C>
       Current ratio                    2.2:1                   4.2:1
       Quick ratio                      2.0:1                   4.0:1
</TABLE>

Safe Harbor Provisions

This report contains forward-looking statements within the meaning of 
the Private Securities Litigation Reform Act of 1995.  These statements 
are subject to a number of important risks and uncertainties that could 
cause actual results to differ materially including, but not limited to, 
economic, competitive, governmental and technological factors affecting 
the Company's operations, markets, products, services and prices.  The 
Company undertakes no obligation to update, amend or clarify forward-
looking statements, whether as a result of new information, future 
events or otherwise.


PART II - OTHER INFORMATION

Item 1 - Legal Proceedings

The following summarizes changes in material litigation from that 
disclosed in the Company's Annual Report on Form 10-KSB for the year 
ended October 31, 1996:

Versus Technology, Inc. v. Duane, Morris & Heckscher:

        Complaint filed:   May 23, 1997
        Court:  United States District Court for the Southern District
        of New York
        Civil Action No.  97 Civ. 3798

     The Company has filed a malpractice law suit against one of its 
former law firms, seeking indemnity against any loss the Company might 
incur in connection with the class action law suits (referenced in the 
Company's October 31, 1996 Annual Report on Form 10-KSB) and also 
seeking equitable relief against the claim that the Company is indebted 
to the law firm for prior legal services. 

Item 6 (a) Exhibits 

  Exhibit 11 - Statement re Computation of Per Share Earnings

  Exhibit 99 (a)  PhoneVision uses IR tracking to provide sight to the
                  telephone

             (b)  Versus Technology, Inc. Appoints Samuel Davis as
                  Director

             (c)  Los Alamos National Laboratories Purchases
                  Nightingale Infrared (IR) Tracking System

  Exhibit 27 - Financial Data Schedule

Item 6 (b) Reports on Form 8-K

There were no reports on Form 8-K for the quarter ended July 31, 1997.

SIGNATURES

       Pursuant to the requirements of Section 13 or 15(d) of the 
Securities Exchange Act of 1934, the registrant has duly caused this 
report to be signed on its behalf by the undersigned, thereunto duly 
authorized.


                                                 VERSUS TECHNOLOGY, INC.
                                                      (Registrant)


                                           By: GARY T. GAISSER          
                                               Gary T. Gaisser
                                               President and Chief
                                               Executive Officer


                                           By: ROBERT BUTLER
                                               Robert Butler
                                               Controller and Chief
                                               Accounting Officer



September 16, 1997



Exhibit 11 - Statement re Computation of Per Share Earnings
<TABLE>
<CAPTION>
                           Three Months Ended     Nine Months Ended
                               July 31,                 July 31,
                         1997             1996 1997                1996
<S>                    <C>         <C>         <C>          <C>
Net loss               $ (797,000) $ (406,000) $(2,044,000) $(1,208,000)

Calculation of 
  weighted average
  common shares
  outstanding:

Outstanding common
  shares at beginning
  of period            38,113,549  18,485,697   36,543,573  18,910,697

Impact of repurchase
  of Former Chairman
  of the Board and 
  CFO's shares                                                (282,299)
Impact of shares
  issued                              254,076                   85,622  
Impact of January 31,
  1997 Precision
  Tracking issue                                 1,064,706
Other                      18,600      (6,159)     (12,907)     (4,017)

Total weighted average
  common shares        38,132,149  18,733,614   37,595,372   18,710,003


Primary and Fully
  Diluted Loss
  per Share              $(.02)     $(.02)        $(.05)        $(.06)

NOTE:  The weighted average effect of common stock equivalents was anti-
dilutive for 1996 and 1997 and, therefore, was not considered in the 
above  
calculation.
</TABLE>

Exhibit 99(a) - PhoneVision uses IR tracking to provide sight to the 
telephone




PhoneVision uses IR tracking to provide sight to the telephone

TRAVERSE CITY, Mich., July22/PRNewswire/--Versus Technology, Inc. 
(NASDAQ Bulletin Board:  VSTI)  announced:

Versus Technology, Inc.  recently announced the addition of PhoneVision 
to their high-tech infrared product line.  PhoneVision, using IR 
technology as its platform, allows someone to use a telephone to locate 
a person or a piece of equipment simply by dialing the appropriate 
extension number. The PhoneVision system automatically locates the 
person and rings the phone nearest to him so all calls are answered 
minimizing phone-tag.  PhoneVision provides time saving benefits to a 
broad range of professions that operate in a fast-paced environment- 
from business offices to healthcare facilities.

PhoneVision provides an IR (infrared) communication solution to the 
frustrating problem of locating a person or piece of equipment in 
seconds. In the fast-paced, time is money world of today, Phone Vision 
offers a viable solution to anyone who knows how to use a telephone.  
PhoneVision allows a facility to use its existing phone system as a 
means to locate key resources.  Notes Vice-President of Versus, Henry 
Tenarvitz,  "What we have done is to simply  merge Versus' infrared 
tracking system with our customers' telephone equipment." 

People and equipment wear a lightweight infrared badge that identifies 
their real-time location to the system.  As the system searches for an 
extension number programmed to an individual's badge, it is smart enough 
to "look" for that person throughout the entire facility.  As the system 
locates the person associated with that extension number, it will inform 
the caller where the person is located (i.e. In the Conference Room).  
PhoneVision then allows the caller to select from two options:  1) to 
ring the extension number where the person is now located  and/or  2)  
to identify who or what else is in the room.  

In a typical office environment, a receptionist  no longer needs to 
search office after office trying to locate a person expecting an urgent 
phone call; he/she only needs to enter the person's extension number and 
PhoneVision will find the employee.   "I can be in the Laboratory after 
switchboard hours," states Versus' President Gary T. Gaisser, "and if 
phone mail is not an acceptable choice for the caller, I have the 
comfort of knowing the call can reach me by way of PhoneVision."   
Valuable time is easily saved, customer service is enhanced, and 
returned phone call costs are nearly eliminated.  Management personnel 
are excited by the time saving benefits PhoneVision provides to their 
organizations.

Equipment can also be easily located via the telephone.   By assigning 
the equipment an ID number and affixing the equipment with an infrared 
tag, the location of the equipment can be determined quickly.  
PhoneVision can identify the location of the item and also identify 
other tagged items in the room.  Knowledge of specific equipment 
location can be a critical issue.  Real-time location eliminates the 
need to guess where an item was last placed and can increase staff 
efficiency.


Versus Technology, Inc. (publicly traded on NASDAQ Bulletin Board:  
VSTI)  manufactures and markets IR (infrared) locating and communication 
systems and phone forwarding integration systems.  Their headquarters 
are located in Traverse City, MI.  Additional information is available 
at the company's website,  http://www.versustech.com or by calling (616) 
946-5868 or FAX (616) 946-6775.




- -0-			7/22/97
/CONTACT:  Gary T. Wittbrodt, 616-946-5868, of Versus Technology, 
Inc./(VSTI)

Exhibit 99(b)   Versus Technology, Inc. Appoints Samuel Davis as 
Director

NEWS RELEASE

Versus Technology, Inc. Appoints Samuel Davis as Director

TRAVERSE CITY, Mich., August 15/PRNewswire/--Versus Technology, Inc. 
(NASDAQ Bulletin Board:  VSTI) announced:

Sam Davis, former President and CEO of the Mt. Sinai Hospital, has been 
named to the Board of Directors of Versus Technology, Inc., effective 
August 14, 1997.  

Mr. Davis is a Clinical Professor at the School of Public Health at 
Columbia University and a Distinguished Service Professor at the Mount 
Sinai School of Medicine.  He is a Senior Director of Delta Consulting 
Group, Inc. specializing in the management of strategic organizational 
change in health care organizations.  Mr. Davis has a distinguished 
academic and professional background in the health care profession and 
has authored numerous published articles.  

"We are gratified that Samuel Davis, with his distinguished background, 
is joining the Versus Board," noted Gary Gaisser, President and CEO of 
Versus Technology.  "His expertise in the health care industry will be 
of particular assistance to the Company, and he will be a valuable asset 
in helping us achieve our strategies.  We look forward to his 
contributions." 

As the former President and CEO of the Mount Sinai Hospital, Mr. Davis 
was responsible for the acknowledged financial and managerial turnaround 
of one of the largest academic medical centers in New York City.  "With 
his knowledge of the financial and managerial needs of health care 
organizations, Mr. Davis is in a unique position to aid Versus in the 
penetration of the health care market," Gaisser commented.

Based in Traverse City, Michigan, Versus Technology manufactures and 
markets infrared locating and communication systems and phone forwarding 
integration systems.  For additional information, please call (616) 946-
5868 or FAX (616) 946-6775 or visit the company's website:  
www.versustech.com


- -0-		8/15/97
/CONTACT:  Gary T. Gaisser, 616-946-5868, of Versus Technology, 
Inc./(VSTI)
Versus Technology, Inc.  2600 Miller Creek Rd., Traverse City, MI  49684 
 616-946-5868   fax 616-946-6775

Exhibit 99(c)   Los Alamos National Laboratories Purchases Nightingale 
                Infrared (IR) Tracking System

NEWS RELEASE



Los Alamos National Laboratories Purchases Nightingale? 
Infrared (IR) Tracking System


TRAVERSE CITY, Mich., September 5/PRNewswire/--Versus Technology, Inc. 
(NASDAQ Bulletin Board:  VSTI) announced:

Versus Technology Inc. announced today that it has received an order 
from Los Alamos National Laboratories to implement a pilot installation 
of its Nightingale? Resource Management System at their laboratory in 
New Mexico.  Los Alamos will be using this pilot as an enhancement to 
their security protocol.  

The Nightingale system uses small digital infrared (IR) transmitters 
that uniquely identify people and equipment moving around in secure 
areas.  Paul Argo of Los Alamos stated, "We consider this infrared 
technology to be a key component in AMISS (Adaptive Multi-Integrated 
Security System), a next generation security system we are developing."  
The Nightingale tracking system will provide a continuous stream of 
information detailing routine movements in a nuclear facility.  This 
"real-time" collected data allows events to be evaluated as they occur.   
Mr. Argo also added, "As its name implies, AMISS will look for 
conditions that are out of the norm and call upon multiple security 
technologies to verify and respond to any anomalies." 

Gary Gaisser, President of Versus Technology, Inc., commented, "We are 
continuously pursuing leading edge concepts like AMISS and have 
participated in several similar projects.  For example, we just 
participated in installing a high-tech hospital floor that includes 
patient monitoring and two-way communication.  We are very excited that 
Los Alamos has selected us to be part of an effort towards creating a 
high-tech security system.

Based in Traverse City, Michigan, Versus Technology manufactures and 
markets infrared locating and communication systems and phone forwarding 
integration systems.  For additional information, please call 616-946-
5868 or FAX 616-946-6775 or visit the company's website:  
www.versustech.com

- -0-			9/05/97
/CONTACT:  Gary T. Wittbrodt, 616-946-5868, of Versus Technology, 
Inc./(VSTI)

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          OCT-31-1997
<PERIOD-END>                               JUL-31-1997
<CASH>                                       2,884,000
<SECURITIES>                                         0
<RECEIVABLES>                                  312,000
<ALLOWANCES>                                    68,000
<INVENTORY>                                    154,000
<CURRENT-ASSETS>                             3,432,000
<PP&E>                                         476,000
<DEPRECIATION>                                 178,000
<TOTAL-ASSETS>                               8,132,000
<CURRENT-LIABILITIES>                        1,594,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       381,000
<OTHER-SE>                                   6,157,000
<TOTAL-LIABILITY-AND-EQUITY>                 8,132,000
<SALES>                                        992,000
<TOTAL-REVENUES>                               992,000
<CGS>                                          485,000
<TOTAL-COSTS>                                  485,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                21,000
<INTEREST-EXPENSE>                              20,000
<INCOME-PRETAX>                            (2,044,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,044,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,044,000)
<EPS-PRIMARY>                                    (.05)
<EPS-DILUTED>                                    (.05)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission